These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22211929)

  • 1. Interaction of 3,4-methylenedioxymethamphetamine and methamphetamine during metabolism by in vitro human metabolic enzymes and in rats.
    Kuwayama K; Tsujikawa K; Miyaguchi H; Kanamori T; Iwata YT; Inoue H
    J Forensic Sci; 2012 Jul; 57(4):1008-13. PubMed ID: 22211929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between 3,4-methylenedioxymethamphetamine, methamphetamine, ketamine, and caffeine in human intestinal Caco-2 cells and in oral administration to rats.
    Kuwayama K; Inoue H; Kanamori T; Tsujikawa K; Miyaguchi H; Iwata Y; Miyauchi S; Kamo N; Kishi T
    Forensic Sci Int; 2007 Aug; 170(2-3):183-8. PubMed ID: 17614227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.
    Yang J; Jamei M; Heydari A; Yeo KR; de la Torre R; Farré M; Tucker GT; Rostami-Hodjegan A
    J Psychopharmacol; 2006 Nov; 20(6):842-9. PubMed ID: 16714321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: use of paroxetine as a metabolic inhibitor probe.
    Segura M; Farré M; Pichini S; Peiró AM; Roset PN; Ramírez A; Ortuño J; Pacifici R; Zuccaro P; Segura J; de la Torre R
    Clin Pharmacokinet; 2005; 44(6):649-60. PubMed ID: 15910012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sprague-Dawley rats display sex-linked differences in the pharmacokinetics of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA).
    Fonsart J; Menet MC; Debray M; Hirt D; Noble F; Scherrmann JM; Declèves X
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):339-47. PubMed ID: 19781562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine).
    Pizarro N; Farré M; Pujadas M; Peiró AM; Roset PN; Joglar J; de la Torre R
    Drug Metab Dispos; 2004 Sep; 32(9):1001-7. PubMed ID: 15319342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
    Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sprague-Dawley rats display metabolism-mediated sex differences in the acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Fonsart J; Menet MC; Declèves X; Galons H; Crété D; Debray M; Scherrmann JM; Noble F
    Toxicol Appl Pharmacol; 2008 Jul; 230(1):117-25. PubMed ID: 18358511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of human hepatic cytochrome P450 isozymes in the metabolism of racemic 3,4-methylenedioxy-methamphetamine and its enantiomers.
    Meyer MR; Peters FT; Maurer HH
    Drug Metab Dispos; 2008 Nov; 36(11):2345-54. PubMed ID: 18725511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Ecstasy influence on tramadol and its main metabolite plasma concentration in rats.
    Jamali B; Sheikholeslami B; Hosseinzadeh Ardakani Y; Lavasani H; Rouini MR
    Drug Metab Pers Ther; 2017 Sep; 32(3):137-145. PubMed ID: 28917081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.
    Ikeda R; Igari Y; Fuchigami Y; Wada M; Kuroda N; Nakashima K
    Eur J Pharmacol; 2011 Jun; 660(2-3):318-25. PubMed ID: 21497593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warning against co-administration of 3,4-methylenedioxymethamphetamine (MDMA) with methamphetamine from the perspective of pharmacokinetic and pharmacodynamic evaluations in rat brain.
    Yuki F; Rie I; Miki K; Mitsuhiro W; Naotaka K; Kenichiro N
    Eur J Pharm Sci; 2013 Apr; 49(1):57-64. PubMed ID: 23395913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: pharmacological effects and pharmacokinetics.
    Farré M; Abanades S; Roset PN; Peiró AM; Torrens M; O'Mathúna B; Segura M; de la Torre R
    J Pharmacol Exp Ther; 2007 Dec; 323(3):954-62. PubMed ID: 17890444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The consequences of 3,4-methylenedioxymethamphetamine induced CYP2D6 inhibition in humans.
    O'Mathúna B; Farré M; Rostami-Hodjegan A; Yang J; Cuyàs E; Torrens M; Pardo R; Abanades S; Maluf S; Tucker GT; de la Torre R
    J Clin Psychopharmacol; 2008 Oct; 28(5):523-9. PubMed ID: 18794647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case of 3,4-Dimethoxyamphetamine (3,4-DMA) and 3,4-Methylenedioxymethamphetamine (MDMA) Toxicity with Possible Metabolic Interaction.
    Darracq MA; Thornton SL; Minns AB; Gerona RR
    J Psychoactive Drugs; 2016; 48(5):351-354. PubMed ID: 27636207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
    Cheng WC; Poon NL; Chan MF
    J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro.
    Ramamoorthy Y; Yu AM; Suh N; Haining RL; Tyndale RF; Sellers EM
    Biochem Pharmacol; 2002 Jun; 63(12):2111-9. PubMed ID: 12110370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.
    Lin LY; Di Stefano EW; Schmitz DA; Hsu L; Ellis SW; Lennard MS; Tucker GT; Cho AK
    Drug Metab Dispos; 1997 Sep; 25(9):1059-64. PubMed ID: 9311621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic interactions between ethanol and MDMA in primary cultured rat hepatocytes.
    Pontes H; de Pinho PG; Fernandes E; Branco PS; Ferreira LM; Carmo H; Remião F; Carvalho F; Bastos ML
    Toxicology; 2010 Apr; 270(2-3):150-7. PubMed ID: 20170704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of metabolite-to-parent drug ratios of methamphetamine and methylenedioxymethamphetamine in hair.
    Han E; Park Y; Yang W; Lee J; Lee S; Kim E; Lim M; Chung H
    Forensic Sci Int; 2006 Sep; 161(2-3):124-9. PubMed ID: 16870374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.